Fluor Corp sells $162.9 million in NuScale Power (SMR) shares By Investing.com

Fluor sold 13.5 million NuScale Power shares at $12.0665 each on April 9, 2026, a $162.9 million transaction that left it with 26.4 million shares. The sale was made under a previously disclosed agreement, tempering the signal, but it comes amid a sharp decline in NuScale's share price to $9.59 and a weaker analyst tone. Recent operational updates on fuel manufacturing expansion and a steam-compressor partnership are offset by multiple price-target cuts, including UBS to $13 from $20 and Craig-Hallum to $24 from $53.

Analysis

The key signal is not the absolute size of the sale, but the fact that a strategic holder is still monetizing into weakness while retaining a large residual stake. That creates an overhang for SMR because the market will infer that any future distribution or liquidity event can be absorbed at lower prices, which compresses the valuation multiple for a pre-revenue nuclear platform. In the near term, that matters more than project headlines: the stock is being traded as a capital-structure and funding story, not an execution story.

Second-order, the name is now caught between a long-dated technology narrative and a short-dated financing reality. The fuel-partnership and industrial-compressor partnerships are useful option value, but they do little to solve the core issue that every incremental milestone likely raises future capex expectations before revenue visibility improves. That tends to benefit larger nuclear incumbents and engineering suppliers with real cash generation, while punishing pure-play SMR exposure when rates are high and risk appetite is selective.

The analyst target resets are important because they signal a broader de-rating in the category: the market is no longer paying for blue-sky deployment curves without clearer project finance, customer commitment, and dilution control. A contrarian bull case would argue that AI-driven power demand eventually forces utilities and hyperscalers to accept first-of-a-kind premiums, but that is a 12-36 month catalyst, not a tape-positive catalyst today. Until then, the stock likely trades on every financing/insider disclosure rather than on technical progress.

For FLR, the sale marginally reduces direct exposure to a volatile asset and may be read as disciplined capital recycling, but it also suggests the parent is prioritizing balance-sheet flexibility over narrative optionality. That can be a quiet negative for any vendor-supplier ecosystem that had hoped Fluor would be an aggressive sponsor of the SMR theme.

Key Decisions for Investors

• Short SMR on strength into any rally above the post-sale implied resistance zone; use a 1-3 month horizon and target a move back toward the high-$8s/low-$9s if no new customer or financing catalyst emerges.
• Pair trade: long cash-generative nuclear/utility exposure vs short SMR; the cleaner expression is long CEG or NEE against SMR for 3-6 months, betting the market rewards visible FCF over pre-revenue optionality.
• Avoid initiating fresh long SMR positions until after the next financing or commercialization catalyst; if long-term bulls want exposure, wait for a lower entry and size it as a call option rather than an equity core holding.
• For FLR holders, treat the transaction as a modest de-risking signal and trim any incremental SMR-linked optimism; the better trade is to own FLR only on project execution, not on NuScale optionality.
• If seeking upside convexity to the AI-power narrative, use small long-dated call spreads rather than stock in SMR; the thesis needs 12-24 months, so avoid paying full equity carry for a story with near-term dilution risk.